![](/img/cover-not-exists.png)
A Phase 2 study of cisplatin analog CI-973 in the treatment of patients with refractory, advanced ovarian cancer
J.A. Roberts, A.P. Kudelka, D.R. Spriggs, F. Muggia, J. Lurain, W. Grove, C. KowalVolume:
6
Year:
1996
Language:
english
Pages:
4
DOI:
10.1046/j.1525-1438.1996.06040257.x
File:
PDF, 389 KB
english, 1996